Provention Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Provention Bio generated cash of -$75,408,000, which is more than the previous year. Cash used in financing activities reached the amount of $129,384,000 last year. Net change in cash is therefore -$34,151,000.
Cash Flow
| 2017 | -4.88M | 0 | 26.71M |
|---|---|---|---|
| 2018 | -22.64M | 0 | 59.34M |
| 2019 | -36.06M | -46.25M | 62.94M |
| 2020 | -76.33M | 25.17M | 114.29M |
| 2021 | -95.38M | -31.09M | 102.37M |
| 2022 | -75.40M | -88.12M | 129.38M |
PRVB Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 78.19M | 102.29M | 39.16M | 58.53M | 21.83M | 0 |
Operating activities | ||||||
Net income | -113.56M | -114.43M | -98.58M | -43.28M | -26.47M | -9.13M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 1.22M | 387K | 33K | -16K | 0 | 0 |
Stock-based compensation expense | 19.02M | 11.83M | 13.22M | 2.84M | 1.14M | 206.72K |
| Deferred income tax benefit | 19.02M | 11.83M | 13.22M | 2.84M | 1.14M | 206.72K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -1.35M | 0 | 0 | 0 | 0 | 0 |
Inventories | -1.23M | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 3.21M | -4.02M | 5.79M | 1.20M | 109K | 459.74K |
Cash generated by operating activities | -75.40M | -95.38M | -76.33M | -36.06M | -22.64M | -4.88M |
Investing activities | ||||||
Purchases Of Investments | -103.08M | -55.28M | -28.71M | -46.25M | 0 | 0 |
Investments In Property Plant And Equipment | -795K | -961K | -1.11M | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -88.12M | -31.09M | 25.17M | -46.25M | 0 | 0 |
Financing activities | ||||||
Common Stock Issued | 104.63M | 102.32M | 113.13M | 62.94M | 59.34M | 1K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 129.38M | 102.37M | 114.29M | 62.94M | 59.34M | 26.71M |
Net Change In Cash | -34.15M | -24.10M | 63.12M | -19.37M | 36.70M | 21.83M |
Cash at end of period | 44.03M | 78.19M | 102.29M | 39.16M | 58.53M | 21.83M |
| Data source | Data source | Data source | Data source | Data source |